These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26886397)

  • 41. Aspirin in coronary artery disease: an appraisal of functions and limitations.
    Würtz M
    Dan Med J; 2015 Apr; 62(4):B5011. PubMed ID: 25872543
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Peri-operative management of antiplatelet therapy in patients with coronary artery disease: joint position paper by members of the working group on Perioperative Haemostasis of the Society on Thrombosis and Haemostasis Research (GTH), the working group on Perioperative Coagulation of the Austrian Society for Anesthesiology, Resuscitation and Intensive Care (ÖGARI) and the Working Group Thrombosis of the European Society for Cardiology (ESC).
    Korte W; Cattaneo M; Chassot PG; Eichinger S; von Heymann C; Hofmann N; Rickli H; Spannagl M; Ziegler B; Verheugt F; Huber K
    Thromb Haemost; 2011 May; 105(5):743-9. PubMed ID: 21437351
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison between urinary 11-dehydrothromboxane B2 detection and platelet Light Transmission Aggregometry (LTA) assays for evaluating aspirin response in elderly patients with coronary artery disease.
    Liu T; Zhang J; Chen X; Feng X; Fu SW; McCaffrey TA; Liu M
    Gene; 2015 Oct; 571(1):23-7. PubMed ID: 26095809
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy.
    Béres BJ; Tóth-Zsámboki E; Vargová K; László A; Masszi T; Kerecsen G; Préda I; Kiss RG
    Thromb Haemost; 2008 Nov; 100(5):829-38. PubMed ID: 18989527
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clopidogrel response variability is associated with endothelial dysfunction in coronary artery disease patients receiving dual antiplatelet therapy.
    Siasos G; Oikonomou E; Zaromitidou M; Kioufis S; Kokkou E; Mourouzis K; Vlasis K; Vavuranakis M; Stone PH; Papavassiliou AG; Tousoulis D
    Atherosclerosis; 2015 Sep; 242(1):102-8. PubMed ID: 26188531
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study.
    Angiolillo DJ; Capranzano P; Goto S; Aslam M; Desai B; Charlton RK; Suzuki Y; Box LC; Shoemaker SB; Zenni MM; Guzman LA; Bass TA
    Eur Heart J; 2008 Sep; 29(18):2202-11. PubMed ID: 18567918
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypertension as a risk factor for aspirin and clopidogrel resistance in patients with stable coronary artery disease.
    Akturk IF; Caglar FN; Erturk M; Tuncer N; Yalcın AA; Surgit O; Uzun F; Caglar IM
    Clin Appl Thromb Hemost; 2014 Oct; 20(7):749-54. PubMed ID: 23493759
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Correlation between the level of the urinary 11-dehydrothromboxane B2 and the clinical efficacy of aspirin in patients with type 2 diabetes and coronary artery disease].
    Liu TF; Zhang JW; Chen XH; Feng XR; Bai ZS; Liu ML
    Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Dec; 47(6):920-4. PubMed ID: 26679651
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antithrombotic therapy in patients with diabetes mellitus and coronary artery disease.
    Ferreiro JL; Cequier ÁR; Angiolillo DJ
    Diab Vasc Dis Res; 2010 Oct; 7(4):274-88. PubMed ID: 20921091
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy.
    Cesari F; Marcucci R; Caporale R; Paniccia R; Romano E; Gensini GF; Abbate R; Gori AM
    Thromb Haemost; 2008 May; 99(5):930-5. PubMed ID: 18449424
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The proinflammatory and hypercoagulable state of diabetes mellitus.
    Aras R; Sowers JR; Arora R
    Rev Cardiovasc Med; 2005; 6(2):84-97. PubMed ID: 15976731
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of hypoglycemic drugs on aspirin resistance in patients with diabetes mellitus.
    Ariturk Z; Islamoglu Y; Gündüz E; Yavuz C; Cil H; Tekbas E; Soydinc S; Kaya H; Elbey MA
    Eur Rev Med Pharmacol Sci; 2012 May; 16(5):617-21. PubMed ID: 22774402
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factors influencing clopidogrel efficacy in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention: statin's advantage and the smoking "paradox".
    Motovska Z; Widimsky P; Petr R; Bilkova D; Marinov I; Simek S; Kala P;
    J Cardiovasc Pharmacol; 2009 May; 53(5):368-72. PubMed ID: 19247187
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Utility of aspirin therapy in patients with the cardiometabolic syndrome and diabetes.
    Gardner M; Palmer J; Manrique C; Lastra G; Gardner DW; Sowers JR
    J Cardiometab Syndr; 2009; 4(2):96-101. PubMed ID: 19614796
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of renal function and platelet turnover on the antiplatelet effect of aspirin.
    Würtz M; Wulff LN; Grove EL; Kristensen SD; Hvas AM
    Thromb Res; 2012 Apr; 129(4):434-40. PubMed ID: 21839494
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Haemodialysis impairs clopidogrel but not aspirin responsiveness in patients with end-stage renal disease. Results of a pilot study.
    Htun P; Kan T; Mueller E; Pohle C; Schindler R; Geisler T; Gawaz M; Bocksch W; Fateh-Moghadam S
    Thromb Haemost; 2014 Apr; 111(4):662-9. PubMed ID: 24337367
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of acetylsalicylic acid and circulating microRNAs in primary prevention of cardiovascular events in patients with Diabetes Mellitus Type 2 - A Review.
    Chabior A; Pordzik J; Mirowska-Guzel D; Postuła M
    Ann Agric Environ Med; 2019 Dec; 26(4):512-522. PubMed ID: 31885222
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization.
    Frelinger AL; Li Y; Linden MD; Barnard MR; Fox ML; Christie DJ; Furman MI; Michelson AD
    Circulation; 2009 Dec; 120(25):2586-96. PubMed ID: 19996015
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antiplatelet therapy for patients with diabetes mellitus and acute coronary syndrome.
    Saucedo JF
    Prim Care Diabetes; 2012 Oct; 6(3):167-77. PubMed ID: 22410305
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An appraisal of dual antiplatelet therapy with clopidogrel and aspirin for prevention of cardiovascular events.
    Terpening C
    J Am Board Fam Med; 2009; 22(1):51-6. PubMed ID: 19124633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.